January 30, 2018
AB Biosciences, Shire in licence deal
AB Biosciences will grant Shire an exclusive worldwide license to develop and commercialize AB Biosciences’ pan receptor interacting molecule (PRIM)…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: AB Biosciences